Hematopoiesis is the process through which blood cells and platelets are produced, differentiated, and maintained. It supplies erythrocytes for oxygen transport, leukocytes for immune defense, and platelets for blood clotting. In adult humans, most production takes place in bone marrow, where hematopoietic stem and progenitor cells generate specialized descendants. The process replaces lost or aging blood components while adjusting production to physiological demand. It encompasses cellular proliferation, lineage commitment, and maturation rather than simply the release of cells into circulation. (niddk.nih.gov)
Development and anatomical sites
The locations and cellular sources of hematopoiesis change during development. Early blood formation begins in the embryonic yolk sac. Later, stem cells capable of sustaining long-term blood production emerge from specialized blood-vessel lining cells, called hemogenic endothelium, associated with the developing aorta. These cells migrate to the fetal liver, where they expand, and subsequently colonize bone marrow. Embryonic blood production therefore includes overlapping stages rather than a single uninterrupted adult-style pathway. (openstax.org)
After birth, red marrow becomes the principal hematopoietic tissue. Its distribution is more extensive in children than in adults. Adult production is concentrated in the vertebrae, pelvis, sternum, cranial bones, and proximal portions of the humerus and femur. Blood formation outside marrow is termed extramedullary hematopoiesis. The liver and spleen can support this process when normal marrow production is insufficient or disrupted; splenic hematopoietic niches also participate in responses to hematopoietic stress. (openstax.org)
Stem cells and lineage commitment
A hematopoietic stem cell combines self-renewal—the ability to produce descendants retaining stem-cell properties—with the capacity to generate multiple blood-cell lineages. Progenitor cells descended from stem cells generally have more restricted developmental potential. Their proliferation amplifies production before terminal maturation, allowing a relatively small stem-cell population to support the continuing renewal of blood. (niddk.nih.gov)
The conventional model organizes hematopoiesis into myeloid and lymphoid branches. Myeloid development includes erythrocytes, platelet-producing megakaryocytes, granulocytes, and monocytes. Lymphoid development includes B cells, T cells, and natural killer cells. This branching scheme remains useful for describing broad relationships, but individual stem and progenitor populations are heterogeneous. Research combining single-cell molecular measurements with functional assays has shown that early lineage commitment can proceed through continuous changes rather than exclusively through sharply separated intermediate compartments. (openstax.org)
Production of mature blood components
Erythropoiesis is the erythrocyte-producing component of hematopoiesis. Immature erythroid cells pass through successive maturation stages before entering circulation as reticulocytes and becoming mature red cells. Its output is closely associated with oxygen delivery: erythropoietin, produced principally by the kidneys, signals marrow to increase red-cell production. Iron, vitamin B12, and folate are required for healthy erythrocyte production, and deficiencies can contribute to anemia. (openstax.org)
Platelets arise from megakaryocytes, large marrow cells that release cellular fragments rather than producing conventional nucleated daughter cells. White-cell development generates several specialized populations, including neutrophils and monocytes. Among lymphocytes, B cells mature in marrow, whereas precursors of T cells migrate to the thymus for maturation. These differences mean that marrow origin does not imply that every blood-cell type completes its development within marrow. (nature.com)
Regulation and the marrow microenvironment
Hematopoiesis depends on both internal cellular programs and external signals. Changes in gene expression help establish lineage identity and control survival, proliferation, and terminal development. Cytokines and other regulatory molecules influence stem and progenitor cells, while cell-cycle control determines whether populations remain relatively inactive or expand. Regulation must preserve long-term regenerative capacity while supplying mature cells at an appropriate rate. (niddk.nih.gov)
The hematopoietic stem-cell niche is the local microenvironment that supports stem-cell maintenance and regulates their activity. Adult marrow niches are closely associated with blood vessels and include endothelial and stromal cells. Stem cell factor and the chemokine CXCL12 are important niche signals. Other cells, including megakaryocytes, macrophages, and neural-associated cells, influence this environment directly or indirectly. The niche is consequently a coordinated cellular system, not merely a physical cavity containing stem cells. (nature.com)
Niches also change across the lifespan. Developing stem cells encounter different environments in the aorta, fetal liver, and marrow, each supporting particular stages of their establishment. Aging alters interactions between stem cells and their surroundings, as well as the composition of marrow tissue. These developmental and age-related differences are important when comparing experimental findings obtained at different life stages. (nature.com)
Disease and transplantation
Disruption of hematopoiesis can reduce the supply of one or more blood components. Kidney disease, for example, can diminish erythropoietin production and thereby contribute to anemia. Blood-cell malignancies such as leukemia affect the hematopoietic system, while intensive chemotherapy and radiation can damage blood-forming stem cells. These conditions involve distinct mechanisms and should not be treated as a single form of “failed blood production.” (niddk.nih.gov)
Hematopoietic stem-cell transplantation restores blood-forming capacity by infusing stem cells collected from peripheral blood, marrow, or umbilical cord blood. Cells may originate from the recipient or a donor. Following infusion, they travel to marrow and establish blood production; this establishment is called engraftment. Recovery of blood-cell counts and restoration of the immune system occur on different timescales, with immune recovery generally taking longer. (cancer.gov)